About
ReThink Pharmaceuticals is a computational biotech company focused on drug repurposing. The company has developed a distinct algorithm based on evolutionary genomics (phylogenetic profiling) and innovative bioinformatics for drug repurposing. ReThink discovers new indications for drugs on the market and under clinical development, as well as for shelved drugs that failed for efficacy reasons in clinical trials. The companys approach aims to expand the spectrum of connections between drugs and diseases, enabling the generation of novel and highly accurate findings. ReThink seeks to work in partnership and collaboration with the pharmaceutical industry, medical institutions, and rare disease foundations to create value by enhancing the potential clinical and commercial success of repurposing options for existing assets.